Is AI/ML Innovations Inc. (AIMLF) a Buy, Sell, or Hold?
OTC : AIMLF
AI/ML Innovations Inc.
$0.02976 USD
$0.0 (10.96%)
- Volume
- 50K
- Average Volume
- 193.86K
- Market Capitalization
- $5.01M
- P/E Ratio
- -1.32
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.06
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.76
Company Overview
OTC
John Paul Duffy
Medical - Healthcare Information Services
Healthcare
AIMLF
5
CA
USD
Liquidity Metrics
0.72
0.76
0.76
0.31
0.00
Sales & Valuation
$167.31K
60.35
45.22
-1.44
-0.02
Profitability
-$0.034
-$4.59M
-5622.25%
-5621.27%
-504.80%
-433.70%
P/E Metrics
-1.32
-0.15
-0.15
Analyst Price Target & Rating
1/5
0 Analysts
%
Financial Health Scores
-49.25
1/9
-$337.59K
$1.63M
$1.41M
-$6.59M
Key Metrics (TTM)
$7.32M
58.37
-1.14
0.76
-504.80%
-404.93%
-61.72%
-69.27%
277 days
Company Executives
| Name | Title |
|---|---|
| Andrea L. Ruth | Head of Quality, Clinical, & Regulatory |
| Erik Suokas | Chief Operating Officer |
| Alan Rabinowitz | Chief Medical Officer, Member of Medical Advisory Board & Director of Medical Partnerships |
| John Paul Duffy | President, CEO & Executive Chairman |
| Kendra Low | Company Secretary |
| Esmat Naikyar | Chief Product Officer |
| Terence Lee | Chief Financial Officer |
Poll Results
No votes yet today — be the first to share your view!
About AI/ML Innovations Inc. (OTC:AIMLF) Stock
Specializing in digital healthcare, AI/ML Innovations Inc. harnesses advanced artificial intelligence and machine learning technologies. The company's core offering is an innovative, patent-pending system for personal health monitoring and management. This platform enables caregivers, patients, and medical professionals to access and utilize vital data, aiming to enhance recovery outcomes and foster healthy living. Additionally, they develop digital health software and wearable technologies. The firm was incorporated in 2009 and, after operating as AIML Resources Inc., rebranded to AI/ML Innovations Inc. in November 2020. Its headquarters are located in Victoria, Canada. ...
AI/ML Innovations Announces Completion of Share Issuance
2026-07-02 17:05:00
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, ON / ACCESS Newswire / July 2, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FSE:42FB) is pleased to announce that it has completed its previously announced share for debt issuance with certain service providers of the Company pursuant to which the Company has issued an aggregate of 3,560,334 common shares (the "Subject Shares") at a deemed price of Cdn$0.05 per Subject Share in consideration of past services and satisfaction of outstanding indebtedness (the "Debt Settlement"). The Subject Shares are subject to a statutory hold period expiring on November 3, 2026.
2026-06-02 07:00:00
Appointments bring more than 50 combined years of cardiac monitoring, ECG overread (the expert clinical review of ECG recordings by trained technicians and cardiologists), and regulatory validation experience to NeuralCloud's clinical and operational leadership team. Leadership additions strengthen AI/ML's clinical-governance and operational readiness as it advances its neural-network ECG signal-processing technology through regulatory review toward potential future commercialization.
AI/ML Innovations Inc. Announces Closing of Final Tranche of Private Placement to Raise $1,917,500
2026-05-11 22:20:00
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, ON / ACCESS Newswire / May 11, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FSE:42FB) is pleased to announce that it has closed the second and final tranche of its previously announced non-brokered private placement (the "Offering") pursuant to which the Company has issued convertible debentures ("Debentures") in the aggregate principal amount of $1,917,500. Together with the first tranche closing, the Company has issued Debentures in the aggregate principal amount of $2,867,500.
AIML Appoints Dr. Martin Green to Medical Advisory Board and Issue Options
2026-05-11 07:00:00
Founding Architect of Canadian Cardiac Electrophysiology and 45-Year Authority on Electrocardiography Joins AIML's Medical Advisory Board TORONTO, ON / ACCESS Newswire / May 11, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce the appointment of Dr. Martin Stephen Green, MD, FRCPC, Professor Emeritus at the University of Ottawa, to the Company's Medical Advisory Board (the "MAB"), effective April 27, 2026. Dr. Green joins the MAB at the invitation of Dr. Paul Dorian, MD, MSc.
AI/ML Innovations Announces Completion of Share Issuance
2026-04-24 19:51:00
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, ON / ACCESS Newswire / April 24, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FSE:42FB) is pleased to announce that it has completed its previously announced share for debt issuance with certain service providers of the Company pursuant to which the Company has issued an aggregate of 17,118,420 common shares (the "Subject Shares") at a deemed price of Cdn$0.05 per Subject Share totalling Cdn$855,921 in consideration of past services and satisfaction of outstanding indebtedness (the "Debt Settlement"). The Subject Shares are subject to a statutory hold period expiring on August 25, 2026.
Frequently Asked Questions
-
What is the current AI/ML Innovations Inc. (AIMLF) stock price?
-
AI/ML Innovations Inc.(OTC:AIMLF) stock price is $0.02976 in the last trading session. During the trading session, AIMLF stock reached the peak price of $0.0625 while $0.0015 was the lowest point it dropped to. The percentage change in AIMLF stock occurred in the recent session was 10.96% while the dollar amount for the price change in AIMLF stock was $0.0.
-
AIMLF's industry and sector of operation?
-
The OTC listed AIMLF is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector.
-
Who are the executives of AIMLF?
-
Andrea L. Ruth | Head of Quality, Clinical, & Regulatory
Erik Suokas | Chief Operating Officer
Alan Rabinowitz | Chief Medical Officer, Member of Medical Advisory Board & Director of Medical Partnerships
John Paul Duffy | President, CEO & Executive Chairman
Kendra Low | Company Secretary -
How many employees does AIMLF have?
-
Number of AIMLF employees currently stands at 5. AIMLF operates from 645 Fort Street, Victoria, BC V8W 1G2, CA.
-
Link for AIMLF official website?
-
Official Website of AIMLF is: https://www.aiml-innovations.com
-
How do I contact AIMLF?
-
AIMLF could be contacted at phone #+1 778 405 3883 and can also be accessed through its website. AIMLF operates from 645 Fort Street, Victoria, BC V8W 1G2, CA.
-
How many shares of AIMLF are traded daily?
-
The average number of AIMLF shares traded daily for last 3 months was 193.86K.
-
What is the market cap of AIMLF currently?
-
The market value of AIMLF currently stands at $5.01M with its latest stock price at $0.02976